Eikon Therapeutics, Inc. - EIKN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 06, 2026 | SCHEDULE 13G/A | FMR LLC | 9.2% | 4,993,906 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 9.2% | 4,993,906 | View |
| May 15, 2026 | SCHEDULE 13G | Innovation Endeavors III LP | 5.0% | 2,723,226 | View |
| May 15, 2026 | SCHEDULE 13G | Innovation Endeavors III GP, LLC | 5.0% | 2,723,226 | View |
| May 15, 2026 | SCHEDULE 13G | Innovation Endeavors IV LP | 0.9% | 498,474 | View |
| May 15, 2026 | SCHEDULE 13G | Innovation Endeavors IV GP, LLC | 0.9% | 498,474 | View |
| May 15, 2026 | SCHEDULE 13G | Innovation Endeavors ET SPV LP | 0.3% | 147,819 | View |
| May 15, 2026 | SCHEDULE 13G | Innovation Endeavors ET SPV GP LLC | 0.3% | 147,819 | View |
| May 13, 2026 | SCHEDULE 13G | PERLMUTTER ROGER M | 5.2% | 2,893,171 | View |
| May 06, 2026 | SCHEDULE 13G | FMR LLC | 7.1% | 3,836,830 | View |
| May 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 7.1% | 3,836,830 | View |
| Apr 29, 2026 | SCHEDULE 13G | BlackRock Portfolio Management LLC | 5.5% | 3,002,737 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.